
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PEPT1 CRISPR/Cas9 KO Plasmid (h) | sc-401259 | 20 µg | $397.00 |
SLC15A1 encodes PEPT1, an apical proton-coupled oligopeptide transporter that mediates uptake of dietary di- and tripeptides and a broad range of peptide-like substrates across epithelial barriers. PEPT1 activity integrates transmembrane H+ gradients with nutrient absorption, linking intestinal transport to cellular amino acid availability and downstream metabolic and stress-response processes. Expression is highest in small intestine and can be induced in other epithelia under inflammatory or metabolic perturbation, influencing substrate flux in barrier tissues. Dysregulated SLC15A1/PEPT1 function has been investigated in contexts including intestinal inflammation, malabsorption phenotypes, and altered handling of peptide-mimetic compounds relevant to pharmacology and toxicology research.
PEPT1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SLC15A1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SLC15A1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SLC15A1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish PEPT1 protein expression.
This CRISPR knockout system enables efficient generation of SLC15A1-deficient cell models for investigation of PEPT1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.